Contract manufacturers prepare for anticipated biosimilars manufacturing demands through expansion and acquisition.
Tim Sturgeon
Advertisement
Tim Sturgeon is a senior analyst at Results Healthcare.
Articles by Tim Sturgeon
Advertisement
Latest Updated Articles
Gearing Up for BiosimilarsPublished: May 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
5
